NeoStem Files Patent Application For Cosmetic Stem Cell Face Lift Technology And Expands Stem Cell Collection Network Into New Jersey

NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, has filed a patent application claiming the proprietary stem cell technology of Vincent C. Giampapa, M.D., F.A.C.S. relating to cosmetic facial rejuvenation, which NeoStem first licensed in February 2009.

More: continued here

Filed under: Cosmetic Medicine on May 9th, 2009